top of page
Search
Biologics R&D: select news
Genetic adjuvants: A paradigm shift in vaccine development and immune modulation
https://pubmed.ncbi.nlm.nih.gov/40336572/
jeanfrancoismaison
May 91 min read
Chronicling the Journey of Pneumococcal Conjugate Vaccine Introduction in India
https://pubmed.ncbi.nlm.nih.gov/40333310/
jeanfrancoismaison
May 81 min read
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine
https://pubmed.ncbi.nlm.nih.gov/40333993/
jeanfrancoismaison
May 81 min read
Goals and strategies in vaccine development against tuberculosis
https://pubmed.ncbi.nlm.nih.gov/40327952/
jeanfrancoismaison
May 71 min read
A potent protective bispecific nanobody targeting Herpes simplex virus gD reveals vulnerable epitope for neutralizing
https://pubmed.ncbi.nlm.nih.gov/40328740/
jeanfrancoismaison
May 71 min read
RatXcan: A framework for cross-species integration of genome-wide association and gene expression data
https://pubmed.ncbi.nlm.nih.gov/40163524/
jeanfrancoismaison
May 61 min read
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cells
https://pubmed.ncbi.nlm.nih.gov/40324075/
jeanfrancoismaison
May 61 min read
Recent advances on gene-related DNA methylation in cancer diagnosis, prognosis, and treatment: a clinical perspective
https://pubmed.ncbi.nlm.nih.gov/40325471/
jeanfrancoismaison
May 61 min read
Neurobiomarkers: Basic Aspects and Their Relevance in Nonclinical Studies
https://pubmed.ncbi.nlm.nih.gov/40326184/
jeanfrancoismaison
May 61 min read
Structural insight into TLR4/MD-2 activation by synthetic LPS mimetics with distinct binding modes
https://pubmed.ncbi.nlm.nih.gov/40325026/
jeanfrancoismaison
May 61 min read
Cytotoxic Signature and IFN-γ Production Dominate CD4+ T-Cell Response During Human Toxoplasmosis
https://pubmed.ncbi.nlm.nih.gov/40035468/
jeanfrancoismaison
May 61 min read
Measles, Mumps, Rubella Immunization and the Resurgence of Measles in America
https://pubmed.ncbi.nlm.nih.gov/40324197/
jeanfrancoismaison
May 61 min read
Populations Addressed in Vaccines Approved via the European Medicines Agency
https://pubmed.ncbi.nlm.nih.gov/40325802/
jeanfrancoismaison
May 61 min read
Combination therapy with cetirizine and anti-PD-1 antibody suppresses colitis-induced colon tumor formation in mice
https://pubmed.ncbi.nlm.nih.gov/40320111/
jeanfrancoismaison
May 51 min read
Perspectives on Implementing Virtual Control Groups in Developmental and Reproductive Toxicity Studies
https://pubmed.ncbi.nlm.nih.gov/40320840/
jeanfrancoismaison
May 51 min read
Phase 3 study of an Ad26.RSV.preF/RSV preF protein vaccine to evaluate the prevention efficacy of RSV-mediated lower tract disease, immunogenicity and safety in Japanese adults
https://pubmed.ncbi.nlm.nih.gov/40319702/
jeanfrancoismaison
May 51 min read
Dual inhibition of TGFβ2,3 is severely toxic, whereas selective inhibition of TGFβ1, 2, or 3 and dual inhibition of TGFβ1,2 is generally tolerated In mouse and cynomolgus monkey toxicology studies
https://pubmed.ncbi.nlm.nih.gov/40317127/
jeanfrancoismaison
May 41 min read
Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries
https://pubmed.ncbi.nlm.nih.gov/40318346/
jeanfrancoismaison
May 41 min read
Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trials
https://pubmed.ncbi.nlm.nih.gov/40318674/
jeanfrancoismaison
May 41 min read
The role of cyclic adenosine monophosphate (cAMP) in pathophysiology of fibrosis
https://pubmed.ncbi.nlm.nih.gov/40318753/
jeanfrancoismaison
May 41 min read
bottom of page